|
Volumn 106, Issue , 2001, Pages 137-154
|
Chemoprevention of breast cancer.
a a |
Author keywords
[No Author keywords available]
|
Indexed keywords
ANTINEOPLASTIC AGENT;
ANTINEOPLASTIC HORMONE AGONISTS AND ANTAGONISTS;
ESTROGEN RECEPTOR;
RALOXIFENE;
SELECTIVE ESTROGEN RECEPTOR MODULATOR;
TAMOXIFEN;
BREAST TUMOR;
CHEMOPROPHYLAXIS;
DRUG ANTAGONISM;
FEMALE;
HUMAN;
PATHOPHYSIOLOGY;
REVIEW;
RISK FACTOR;
ANTICARCINOGENIC AGENTS;
ANTINEOPLASTIC AGENTS, HORMONAL;
BREAST NEOPLASMS;
CHEMOPREVENTION;
FEMALE;
HUMANS;
RALOXIFENE;
RECEPTORS, ESTROGEN;
RISK FACTORS;
SELECTIVE ESTROGEN RECEPTOR MODULATORS;
TAMOXIFEN;
MLCS;
MLOWN;
|
EID: 0035226932
PISSN: 09273042
EISSN: None
Source Type: Journal
DOI: 10.1007/978-1-4615-1657-6_6 Document Type: Review |
Times cited : (4)
|
References (95)
|